Shabbir M.H. Alibhai

Papers

Total Citations

H-Index

About

Dr. Shabbir M.H. Alibhai is a leading clinician-scientist whose research focuses on improving the quality of life and treatment outcomes for older adults with cancer, particularly those with genitourinary malignancies. His major contributions lie in understanding how cancer and its treatments—especially prostate cancer therapies—affect physical function, cognition, and health-related quality of life (HRQoL). In a highly cited 2015 study, Dr. Alibhai investigated HRQoL outcomes in men undergoing robotic versus open radical prostatectomy, providing critical evidence to guide surgical decision-making. His work has been cited over 9,000 times, reflecting its profound impact on geriatric oncology and urologic oncology. Notably, he has pioneered research on the effects of androgen deprivation therapy on cognitive decline and frailty, and he has developed innovative supportive care interventions to mitigate these toxicities. Dr. Alibhai’s influential studies have shaped clinical guidelines and improved the holistic management of older cancer patients, making him a key figure in advancing patient-centered care for this vulnerable population.